期刊文献+

甲状腺功能减退性肌病合并糖尿病1例报告及文献复习

A Case Report of Hypothyroidism Myopathy with Diabetes and Literatures Review
下载PDF
导出
摘要 【目的】提高对甲状腺功能减退性肌病的认识和诊治水平。【方法】报道甲状腺功能减退性肌病1例,并检索2000~2006年中国期刊全文数据库检索国内报道及PUBMED上检索到的国外文献,进行汇总研究,并讨论该病相应进展。【结果】病例为中年男性,合并糖尿病,2周甲状腺激素替代治疗后效果好。共检索到国内报道16例,国外报道若干例,多为男性患者。发病机制可能与遗传、甲状腺机能减退代谢异常以及自身免疫有关。肌无力、肌痛是普遍存在的症状。肌酸激酶常中度升高。一般肌电图和肌活检无特异性改变。【结论】甲状腺功能减退性肌病好发于男性,该病患者具有甲状腺功能减退的症状群和肌病的症状群。甲状腺激素替代是主要治疗手段。该病预后尚好。 [Objective]To increase our knowledge of hypothyroidism myopathy and improve its diagnosis and treatment. [Methods]A case of hypothyroidism myopathy combined with diabetes mellitus was reported. CJFD cases reported in the Chinese literatures from January, 2000 till 2006 and foreign literatures by PUBMED were reviewed, [Results]This case was a middle-aged male with diabetes. The symptoms and signs were significantly improved after thyroid hormone replacement for two weeks. Altogether 16 internal cases and many foreign cases, most of whom were male, were found. Its mechanism might be related with heredity ,immunity and metabolism. CK was moderately elevated. Usually no specific signs could be found on muscle biopsy. Muscle weakness and myalgia were common symptoms. The electromyography and muscle biopsy were usually not specific. [Conclusion]The incidence of hypothyroidism myopathy of male is higher than that of females. The clinical manifestations include symptoms of both hypothyroidism and myopathy. Thyroid hormone replacement therapy is the main treatment. Its prognosis is usually good.
出处 《医学临床研究》 CAS 2007年第10期1682-1684,共3页 Journal of Clinical Research
关键词 甲状腺功能减退症/并发症 肌疾病 糖尿病 hypothyroidism/CO muscular diseases diabetes mellitus
  • 相关文献

参考文献12

  • 1Leite AC.Hoffman's syndrome:pseudohypertrophic myopathy as initial manifestation of hypothyroidism.Case report[J].Arq Neuropsiquiatr,2003,61(3B):851-854.
  • 2Kamat JR Tullu MS,Udgirkar VS.Kocher-Debre-Semelaigne syndrome:hypothyroidism with muscle pseudohypertrophy[J].Indian J Pediatr,2003,70(8):671-673.
  • 3Madafiaga MG.Polymyositis-like syndrome in hypothyroidism:review of cases reported over the past twenty-five years[J].Thyroid,2002,12(4):331-336.
  • 4Sicilisno G,Monzani F Murfi L.Human mitochondrial transcription factor A reduction and mitochondrial dysfunction in Hashimoto's hypothyroid myopathy[J].Mol Med,2002,8(6):326-333.
  • 5Sinclair C,Gilchrist JM,Kandula M.Muscle carnitine in hypoo-and hyperthyroidism[J].Muscle Nerve,2005,32(3):357-359.
  • 6Ozdag F,Akar A,Erbil H.Acute rhabdomyolysis during the treatment of scleromyxedema with interferon alfa[J].J Dermatolog Treat,2001,12(3):167-169.
  • 7Monici MC,Rodolico C,Vita G.Apoptosis and apoptosis-related proteins in thyroid myopathies[J].Muscle Nerve,2002,26(3):383-388.
  • 8Tokinaga K,Oeda T,Matsushima.HMG-CoA Reductase Inhibitors(statins) Might Cause High Elevations of Creatine Phosphokinase(CK)in Patients with Unnoticed Hypothyroidism[J].Endocr J,2006,53(3):401-405.
  • 9Lai CL,Hypothyroid myopathy-pathological and ultrastructural study[J].Kaohsiung J Med Sci,2000,16(2):68-75.
  • 10Scott KR,Simmons Z,Boyer PJ.Hypothyroid myopathy with a strikingly elevated serum creatine kinase level[J].Muscle Nerve,2002,26(1):141-144.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部